Clinical studies recruiting near Norwich

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Eastern CT Hematology & Oncology Associates ( Site 0033) · Merck Sharp & Dohme LLC · NCT06136559 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Investigational Site Number : 8260004 · Sanofi · NCT07190196 Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Phase 1/Phase 2 · Eastern Connecticut Hematology and Oncology Associates · Revolution Medicines, Inc. · NCT07397338 Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · Eastern Connecticut Hematology and Oncology Associates · Pfizer · NCT07421700 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 Post-Market Study to Assess iTind Safety in Comparison to UroLift
NA · Norfolk & Norwich University Hospital · Olympus Corporation of the Americas · NCT04757116 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Norfolk and Norwich University Hospital · Janssen Research & Development, LLC · NCT07499232 Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Phase 2 · Norfolk and Norwich University Hospital · Cambridge University Hospitals NHS Foundation Trust · NCT05093231 Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
NA · Norfolk and Norwich University Hospital · University College, London · NCT05604963 A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorecta
Phase 1 · Eastern Ct Hema/Onco Assoc · Hoffmann-La Roche · NCT04929223 Visugromab in Cachexia International Trial
Phase 2/Phase 3 · Eastern Connecticut Hematology & Oncology · CatalYm GmbH · NCT07112196 Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal
Phase N/A · Norfolk and Norwich University Hospital · International Extranodal Lymphoma Study Group (IELSG) · NCT05700149 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Boehringer Ingelheim · NCT06531824 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Eastern Connecticut Hematology and Oncology Associates · Amgen · NCT07005128 International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
Phase 3 · Norfolk and Norwich University Hospitals NHS Foundation Trus · Institute of Cancer Research, United Kingdom · NCT02305654 A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Phase 2 · Norfolk and Norwich University Hospital - Norfolk and Norwic · Gesynta Pharma AB · NCT07260669 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Eastern CT Hematology & Oncology Associates ( Site 0202) · Merck Sharp & Dohme LLC · NCT06623422 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 GEMINI-NSCLC: NSCLC Biomarker Study
Phase N/A · Eastern CT and Hematology and Oncology Associates · Tempus AI · NCT05236114 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Phase N/A · Norfolk and Norwich Hospital · Abbott Medical Devices · NCT03876054 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site GB005 · Incyte Corporation · NCT07522073 A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).
Phase 1/Phase 2 · Norfolk and Norwich University Hospital · Eupraxia Pharmaceuticals Inc. · NCT05608681 A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Phase 2 · Norfolk & Norwich University Hospital NHS Foundation Trust ( · Merck Sharp & Dohme LLC · NCT07133633 Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Phase 2 · Research Site · AstraZeneca · NCT06526793 Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
Phase 3 · Norfolk and Norwich University Hospital · Monash University · NCT05072314 Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms
Phase N/A · Norfolk and Norwich University Hospitals NHS Foundation Trus · Imperial College London · NCT06169163 Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
Phase 3 · Norfolk and Norwich University Hospital · The University of Queensland · NCT04939935 Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Phase N/A · Norfolk and Norwich University Hospital, Norfolk and Norwich · University of Leeds · NCT04102930 Εffectiveness of a Digital Social Intervention in Primary Care
NA · East of England Regional Research Delivery Network · Queen Mary University of London · NCT06849245 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263

Look up another city

Look up another condition